Valuation (33%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.21 | -18.85 |
| PEG Ratio (TTM) | 0.00 | -5.55 |
| P/S Ratio (TTM) | 4.09 | 47.93 |
| P/B Ratio (TTM) | 0.18 | 30.93 |
| P/FCF Ratio (TTM) | -0.27 | -6.05 |
| Price to 5YR AVG Earnings Ratio | N/A | -5.89 |
| Price to 5YR AVG FCF Ratio | N/A | -14.04 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -84.64% | -18.10% |
| ROE (TTM) | -81.66% | 28.82% |
| Net Profit Margin (TTM) | -1,615.79% | -459.49% |
| ROIC 5YR AVG | N/A | -3.62% |
Growth (10%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -5.73% | -1,181.97% | N/A |
| Revenue | -25.00% | 1,010.13% | N/A |
| Net Income | 1.51% | -1,909.13% | N/A |
| Cash Flow | -6.49% | -2,818.34% | N/A |
Health (32%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 14.81 | 5.75 |
| Quick Ratio (TTM) | 14.81 | 5.53 |
| D/E Ratio (TTM) | N/A | 1.07 |
| Interest Coverage (TTM) | N/A | -7.55 |
| Piotroski F-Score | 3 | 5 |
| Altman Z-Score | N/A | 12.99 |
| LTL to 5YR AVG FCF | N/A | 0.07 |
| Shares Outstanding Growth 5YR AVG | N/A | 40.44% |